Abstract:Abstract Background Whether on a global scale or within China, the issue of bacterial antimicrobial resistance (AMR) has become a pressing concern. This study aimed to comprehensively investigate the disease burden of infectious diseases and AMR in China. Methods Data on infectious diseases and AMR were collected by the Global Antimicrobial Resistance Burden study 2019 database. Our analysis steps consisted of 5 broad components: estimating the disease burdens of the total and 12 infectious syndromes by age and sex; describing the burden caused by 43 pathogens; calculating the burden caused by bacterial AMR in two scenarios (AMR associated deaths, AMR attributable deaths), respectively; estimating the AMR burden of 22 bacteria; calculating the burden of AMR by 22 bacteria and 19 antibiotics combinations. Results In 2019, there were an estimated 1.3 million (95% UI 0.8-1.9) infection-related deaths in China, accounting for 12.1% of the total deaths for that year. Males were 1.5 times more affected than females. Bloodstream infections was the largest fatal burden syndrome, associating with 521392 deaths (286307-870583), followed by lower respiratory infections (373175 deaths), and peritoneal and intra-abdominal infections (152087 deaths). These five leading pathogens were S aureus, A baumannii, E coli, S pneumoniae, and E spp., which were associated with 41.2% (502658/1218693) of all infection-related deaths. The pathogens of different infectious syndromes exhibit significant heterogeneity. In 2019, 602561 deaths were associated with bacterial AMR, including 145465 deaths attributable to bacterial AMR. Six leading pathogen-drug combinations were responsible for more than 0.5 million deaths in 2019: macrolides resistance S aureus, fourth-generation cephalosporins resistance A baumannii, carbapenems resistance A baumannii, third-generation cephalosporins resistance A baumannii, aminopenicillin resistance E coli, macrolides resistance S pneumoniae.Figure 1:Number and rate of deaths by pathogens in China, 2019. (A) Number; (B) Rate per 100000 populationFigure 2:Number of deaths associated with bacterial antimicrobial resistance by pathogen-drug combination in China, 2019 Conclusion This study provides the comprehensive assessment of the burden of infectious diseases and bacterial AMR in China. The annual death toll of 1.3 million infection-related deaths, including 600000 deaths related to antibiotic resistance, requires sufficient attention. Disclosures All Authors: No reported disclosures

An Investigation into Socio-economic Impact of Adverse Drug Reactions of Antibacterial Agent Irrational Use

An analysis on antibacterial drug use and drug resistance of Gram-negative bacilli from 2002 to 2005

The Clinical and Economic Impact of Antibiotic Resistance in China: A Systematic Review and Meta-Analysis

Analysis on 522 cases of antibacterial-related adverse drug reaction/event reports

Impact of a Special National Antimicrobial-Stewardship Campaign in China: Irrational Antibiotics Use Was Greatly Decreased but Formidable Problems Remain to Be Overcome

Analysis on 428 Cases Adverse Drug Reaction/event Reports of Antibacterial Agents

Analysis of 114 Severe ADR Cases Induced by Antibacterial Drugs in Our Hospital

Analysis of rational use of antibacterial in a college hospital

The Current Status of Clinical Application of Antimicrobial Agents in China and Consideration on the Rational Drug Use

Analysis on Adverse Drug Reactions in Our Hospital from 2008 to 2010

OP115 Effect of Multiple Drug Resistance on Costs for Patients with Intra-Abdominal Infections in China

Analysis of the Adverse Drug Reactions Reports of 139 Cases

[Impact of Misuse of Antimicrobial Therapies on Inpatient Costs].

Massive Misuse of Antibiotics by University Students in All Regions of China: Implications for National Policy

1808. Burden of infectious diseases and bacterial antimicrobial resistance in China, 2019: a systematic analysis

Effect of Multiple Drug Resistance on Total Medical Costs among Patients with Intra-Abdominal Infections in China.

Exploring the Impact of the Rational Antibiotic Use System on Hospital Performance: The Direct Effect and the Spillover Effect

Indicators of Antibiotics in Outpatient Prescriptions and Irrational Drug Use Analysis

Analysis of the impact of Special Rectification Activities on Clinical Use of Antibacterials

Influence of Rational use of Antibacterial Drugs on Drug Resistance of Pathogenic Bacteria in Nosocomial Infection

Analysis on 342 Repors and Discssion about the Methods of Prevention with Adverse Drug Reactions/events